Distiller L A, Kramer B D
Centre for Diabetes and Endocrinology, Johannesburg.
S Afr Med J. 1996 Aug;86(8 Suppl):1018-20.
Patients with diabetes mellitus who require insulin therapy have always been thought to be at high risk of motor vehicle accidents, primarily because of the possibility of hypoglycaemic events while driving. There are, however, no specific guidelines in South Africa that allow for a rational decision as to when a diabetic is medically fit to drive. The Road Traffic Ordinance simply states that 'Patients with uncontrolled diabetes should be forbidden to drive'. No guidelines are given as to what constitutes 'uncontrolled diabetes'. The situation is not much clearer internationally, where various countries have different laws in this regard. Diabetics on insulin therapy are not restricted from driving private vehicles in any country, but the laws regarding commercial vehicle driving by diabetics on insulin are widely disparate. The actual increased risk of motor vehicle accidents incurred by diabetic drivers on insulin is also uncertain, there being wide variations in the risk rate in different publications. Literature review does suggest, however, that diabetics are probably at a slightly increased risk of traffic violations and accidents compared with the general population, but that this increased overall risk is slight and probably acceptable. There are, however, no known actual statistics for South Africa and any rational guidelines on driving for diabetics on insulin in this country will need to be based on international experience, mostly gleaned from the USA and Western Europe. The decision as to whether a diabetic on insulin should be allowed to drive (either a private vehicle or, more often, a commercial vehicle) is frequently left to the attending doctor. Appropriate guidelines, based on international experience, are suggested.
一直以来,需要胰岛素治疗的糖尿病患者都被认为是机动车事故的高危人群,主要原因是驾车时可能发生低血糖事件。然而,南非并没有具体的指导方针,以便就糖尿病患者何时在医学上适合驾车做出合理决策。《道路交通条例》只是简单规定,“糖尿病控制不佳的患者应禁止驾车”。但对于什么是“糖尿病控制不佳”并未给出指导方针。在国际上,情况也没有更清晰,各个国家在这方面有着不同的法律。在任何国家,接受胰岛素治疗的糖尿病患者驾驶私家车都不受限制,但关于接受胰岛素治疗的糖尿病患者驾驶商用车的法律却大相径庭。接受胰岛素治疗的糖尿病司机实际发生机动车事故的风险增加情况也不确定,不同出版物中的风险率差异很大。然而,文献综述确实表明,与普通人群相比,糖尿病患者交通违规和事故的风险可能略有增加,但总体风险增加幅度较小,可能是可以接受的。然而,南非并没有已知的实际统计数据,该国关于接受胰岛素治疗的糖尿病患者驾车的任何合理指导方针都需要基于国际经验,这些经验大多来自美国和西欧。关于是否应允许接受胰岛素治疗的糖尿病患者驾车(无论是私家车,还是更常见的商用车)的决策,通常由主治医生做出。基于国际经验,本文提出了适当的指导方针。